Advanced Search


Study ID Status Title Patient Level Data
112509 Relinquished Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects with Advanced Myelodysplastic Syndrome (MDS) or secondary Acute Myeloid Leukemia after MDS (sAML/MDS)
112517 Relinquished A phase III, open label, randomized, multicenter trial of ofatumumab maintenance treatment versus no further treatment in subjects with relapsed chronic lymphocytic leukemia (CLL) who have responded to induction therapy
112523 Completed A Pilot Study of a Thrombopoietin-receptor Agonist (TPO-R agonist), Eltrombopag, in Aplastic Anemia Patients with Immunosuppresive-therapy Refractory Thrombocytopenia
112534 Completed A 2-Part trial: a randomized 6-day repeat-dose, parallel-group study in subjects with T2DM to assess the safety and tolerability of GSK1614235 compared to placebo and sitagliptin; and a randomized single-dose, food effect study in healthy volunteers to assess safety and tolerability of GSK1614235
112558 Completed A single dose and repeat dose study to investigate the pharmacokinetics of ropinirole after single and multiple doses of a PR-formulation in Chinese healthy male and female subjects
112560 Completed Epidemiological, observational, post marketing study of the genetic stability of GSK Biologicals’ rotavirus vaccine (Rotarix™) in children <5 years of age diagnosed with severe gastroenteritis, in Belgium
112564 Relinquished A Multicenter, Open-Label, Phase II Study of lapatinib in Combination with Vinorelbine in Subjects with ErbB2 Amplified Recurrent and Metastatic Breast Cancer
112565 Completed AMBITION: A Randomised, Multicenter Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension (PAH)
112571 Completed A double-blind, randomized, placebo controlled Phase II study to evaluate the pharmacodynamics, safety, tolerability, and pharmacokinetics of Single Doses of the Oral Motilin Receptor Agonist GSK962040, in critically ill male and female patients with enteral feed intolerance Study Listed on
112574 Completed A Phase III study to demonstrate the antiviral activity and safety of dolutegravir in HIV-1 infected adult subjects with treatment failure on an integrase inhibitor containing regimen.
112581 Completed An open-label primary vaccination study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ Inactivated Poliomyelitis vaccine Poliorix administered as a three-dose primary vaccination course at 2, 3 and 4 months of age in healthy infants in China. Study Listed on
112582 Completed A multi-centre, double-blind, randomised, parallel-group, active controlled study to evaluate the efficacy, safety and tolerability of tafenoquine (SB-252263, WR238605) in subjects with Plasmodium vivax malaria. Study Listed on
112584 Completed Immunogenicity and safety of GlaxoSmithKline Biologicals’ DTPa-IPV/Hib (Infanrix-IPV+Hib™) in infants
112593 Completed Utility of the cantharidin-induced skin blister assay for evaluation of anti-inflammatory effects of macrolides in healthy volunteers
112595 Completed Impact on nasopharyngeal carriage, acute otitis media, immunogenicity and safety of GSK Biologicals’ pneumococcal conjugate vaccine 1024850A Study Listed on
112597 Completed Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence
112598 Completed Adherence of patients taking 5ARI vs 5ARI + alpha blocker combination therapy in Enlarged Prostate
112599 Completed Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment
112602 Terminated Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
112604 Completed Comparison of Healthcare Utilization and Costs in Patients with Asthma who Fluticasone/Salmeterol Inhalation Powder versus other Inhaled Corticosteroid(s) in Typical Clinical Practice Using Health Insurance Claims Data.
112605 Completed Outcomes for Medicare asthma patients taking fluticasone propionate/salmeterol xinafoate combination versus Inhaled Corticosteroids or other combination therapy
112606 Completed Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
112607 Completed Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
112608 Completed Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects that Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
112609 Completed Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate–Salmeterol Combination Versus Other Maintenance Therapies



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.